Page 60 - Škrgat, Sabina, ed. 2023. Severe Asthma Forum - Monitoring and Treatable Traits in Severe Asthma. Koper: University of Primorska Press. Severe Asthma Forum, 2
P. 60
jects. Am J Respir Crit Care Med. 17. Wardlaw AJ, Brightling C, Green R,
1995; Jul;152(1):53-8. et al. Eosinophils in asthma and oth-
severe asthma forum 2: severe asthma - monitoring and treatable traits in severe asthma 8. Djukanović R, Sterk PJ, Fahy JV, et al. er allergic diseases. Br Med Bull.
Standardised methodology of sputum 2000;56(4):985-1003.
induction and processing. Eur Resp J
Suppl. 2002 Sep:37:1s-2s. 18. Wynn TA. IL-13 effector functions.
9. Weiszhar Z, Horvath I. Induced spu- Annu Rev Immunol. 2003;21:425-56.
tum analysis: step by step. Breathe.
2013;9(4):300-6. 19. Dragonieri S, Elisiana Carpagnano G.
10. Efthimiadis A, Spanavello A, Hamid Biological therapy for severe asthma.
Q, et al. Report of Working Group 3. Asthma Res Pract. 2021 Aug 13;7(1):12.
Methods of sputum processing for cell doi: 10.1186/s40733-021-00078-w.
counts, immunocytochmistry and in
situ hybridisation. Eur Respir J. Supp. 20. Simpson JL, Scott R, Boyle MJ, Gib-
2002 Sep:37:19s-23s. son PG. Inflammatory subtypes in asth-
11. Wenzel SE. Asthma: defining of the per- ma: assessment and identification us-
sistent adult phenotypes. Lancet. 2006 ing induced sputum. Respirology. 2006
Aug 26;368(9537):804-13. Jan;11(1):54-61.
12. Woodruff PG, Khashayar R, Lazarus
SC, et al. Relationship between airway 21. Douwes J, Gibson P, Pekkanen J, Pearce
inflammation, hyperresponsiveness, and N. Noneosinophilic asthma: importance
obstruction in asthma. J Allergy Clin and possible mechanisms. Thorax. 2002
Immunol. 2001 Nov;108(5):753-8. Jul;57(7):643-8.
13. Deykin A, Lazarus SC, Fahy JV, et al.
Sputum eosinophil counts predict asth- 22. Ordonez CL, Shaughnessy TE, Mat-
ma control after discontinuation of in- thay MA, Fahy JV. Increased neutro-
haled corticosteroids. J Allergy Clin Im- phil numbers and IL-8 levels in airway
munol. 2005 Apr;115(4):720-7. secretions in acute severe asthma. Am J
14. Jayaram L, Pizzichini MM, Cook RJ, Respir Crit Care Med. 2000 Apr;161(4
et al. Determining asthma treatment by Pt 1):1185-90.
monitoring sputum cell counts: effect
on exacerbations. Eur Respir J. 2006 23. Sur S, Crotty TB, Kephart GM, et al.
Mar;27(3):483-94. Sudden-onset fatal asthma. Am Rev
15. Fabbri LM, Romagnoli M, Corbetta Respir Dis. 1993 Sep;148(3):713-9.
L, et al. Differences in airway inflam-
mation in patients with fixed airflow 24. Jatakanon A, Uasuf C, Maziak W, Lim
obstruction due to asthma or chron- SM, Chung KF, Barnes PJ. Neutro-
ic obstructive pulmonary disease, Am. philic inflammation in severe persistent
J. Respir. Crit. Care Med. 2003 Feb asthma. Am J Respir Crit Care Med.
1;167(3):418-24. 1999;Nov;160(5 Pt 1):1532-9.
16. Garty BZ, Kosman E, Ganor E, et
al. Emergency room visits of asth- 25. Li AM, Tsang TWT, Chan DFY, et al,
matic children, relation to air pollu- Cough frequency in children with mild
tion, weather, and airborne allergens. asthma correlates with sputum neutro-
Ann Allergy Asthma Immunol. 1998 phil count. Thorax. 2006 Sep;61(9):747-
Dec;81(6):563-70. 50.

26. Pavord ID, Birring SS, Berry M, et al.
Multiple inflammatory hits and the
pathogenesis of severe airway disease.
Eur Respir J. 2006 May;27(5):884-8.

27. Chastre J, Fagon JY, Soler P, et al. Di-
agnosis of nosocomial bacterial pneu-
monia in intubated patients undergoing
ventilation: comparison of the useful-
ness of bronchoalveolar lavage and the
   55   56   57   58   59   60   61   62   63   64   65